RECELL® Autologous Cell Harvesting Device

DEVICE4 trials

Sponsors

Avita Medical, Yale University

Conditions

BurnsHead and Neck CancerHead and Neck TraumaSkin; DeformityVitiligo

Unknown Phase

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

CompletedNCT03333941

Avita MedicalBurns

Start: 2017-10-26End: 2019-05-08Updated: 2024-07-30

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

TerminatedNCT03624192

Avita MedicalSkin; Deformity

Start: 2018-09-19End: 2020-01-13Updated: 2024-07-18

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

CompletedNCT05971381

Avita MedicalVitiligo

Start: 2023-08-14End: 2025-01-31Updated: 2025-02-06

Skin Color Matching in Head and Neck Reconstructive Surgery

RecruitingNCT07431099

Yale UniversityHead and Neck Cancer, Head and Neck Trauma

Start: 2026-05-20End: 2028-09-01Target: 20Updated: 2026-05-29

Related Papers

537 Autologous Skin Cell Suspension for the Treatment of Small (≤10% TBSA) Mixed-Depth Burns

Journal of Burn Care & Research2021-04-01